Evidence map›Paper›PMID 42731992›Full record

ArticleThe EMBO journal2026

Microtubule posttranslational modifications provide unique recognition patterns for associated proteins.

Arya Krishnan, Eva Desvigne-Hansch, Veronique Henriot, Alica Dodoková, Sinda Khanfir, Mariya Genova, Lenka Grycova, Maria M Magiera, Marcus Braun, Zdenek Lansky and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Arya KrishnanInstitut Curie, Université PSL, CNRS UMR3348, Inserm U1368, Genome, RNA and Cancer, Orsay, France.
Eva Desvigne-HanschInstitut Curie, Université PSL, CNRS UMR3348, Inserm U1368, Genome, RNA and Cancer, Orsay, France.
Veronique HenriotInstitut Curie, Université PSL, CNRS UMR3348, Inserm U1368, Genome, RNA and Cancer, Orsay, France.
Alica DodokováInstitute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
Sinda KhanfirInstitut Curie, Université PSL, CNRS UMR3348, Inserm U1368, Genome, RNA and Cancer, Orsay, France.ORCID http://orcid.org/0000-0003-3926-361X
Mariya GenovaInstitut Curie, Université PSL, CNRS UMR3348, Inserm U1368, Genome, RNA and Cancer, Orsay, France.
Lenka GrycovaInstitute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.ORCID http://orcid.org/0000-0002-6476-3627
Maria M MagieraInstitut Curie, Université PSL, CNRS UMR3348, Inserm U1368, Genome, RNA and Cancer, Orsay, France.ORCID http://orcid.org/0000-0003-4847-3053
Marcus BraunInstitute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.ORCID http://orcid.org/0000-0003-2026-2238
Zdenek LanskyInstitute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic. zdenek.lansky@ibt.cas.cz.ORCID http://orcid.org/0000-0001-8474-053X
Carsten JankeInstitut Curie, Université PSL, CNRS UMR3348, Inserm U1368, Genome, RNA and Cancer, Orsay, France. Carsten.Janke@curie.fr.ORCID http://orcid.org/0000-0001-7053-2000

Funding

Agence Nationale de la Recherche (ANR) ANR-10-IDEX-0001Agence Nationale de la Recherche (ANR) ANR-11-LBX-0038Agence Nationale de la Recherche (ANR) ANR-20-CE13-0011EC | ERDF | European Observation Network for Territorial Development and Cohesion (ESPON) CZ.02.1.01/0.0/ 0.0/16_013/0001775EC | Horizon Europe | Excellent Science | HORIZON EUROPE European Research Council (ERC) 101071583European Molecular Biology Organization (EMBO) STF 8843Fondation pour la Recherche Médicale (FRM) EQU202203014694Fondation pour la Recherche Médicale (FRM) FDT202204014706Fondation pour la Recherche Médicale (FRM) FDT202304016528Fondation pour la Recherche Médicale (FRM) MND202003011485Grantová Agentura České Republiky (GAČR) 25-16671SMinisterstvo Školství, Mládeže a Tělovýchovy (MEYS) LM2015043Ministerstvo Školství, Mládeže a Tělovýchovy (MEYS) LM2018129
6 · The paper itself

Abstract

Microtubules are key components of the eukaryotic cytoskeleton involved in vital functions in virtually every cell. Among the emerging molecular mechanisms to adapt microtubules to their diverse functions is the biochemical diversification of tubulin molecules by posttranslational modifications (PTMs) and differential gene expression, a concept known as the 'tubulin code'. A key question remains whether the tubulin code has the potential to selectively control microtubule interactions of different microtubule-associated proteins (MAPs) to act as a specific signalling system. To answer this question, we used a medium-throughput in vitro approach to screen 46 proteins for their binding preferences to microtubules with altered PTM or isotype composition. We demonstrate that subsets of these MAPs have unique sensitivities to PTMs, while other proteins are not affected. As a result, PTMs, or combinations of them, differentially attract or repulse individual MAPs to microtubules. Our findings offer mechanistic proof for a key hypothesis of the tubulin code-the capacity to selectively and differentially regulate MAP-microtubule interactions.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.